Bristol Myers Squibb announces leadership transition plan
Bristol Myers Squibb announced that Dr. Giovanni Caforio, chairman of the board and chief executive officer, has decided to retire as chief executive officer, effective November 1, 2023.
CDR
Kaiser Permanente and Geisinger team
In an innovative move designed to improve the health of communities, achieve better health care outcomes, and improve health care affordability, Kaiser Foundation Hospitals and Geisinger Health are announcing the launch of Risant Health and a definitive agreement to make Geisinger the first health s
Newsweek and BrandSpark International announce the 2nd Annual OTC Brands Trusted the Most by American Pharmacists
Today, market research firm BrandSpark International, in partnership with Newsweek Magazine, released its highly anticipated second annual BrandSpark/Newsweek Most Trusted by Pharmacists Awards (“BMTPhA”) for over-the-counter (“OTC”) consumer product brands.
NACDS Foundation adds new board members
PALM BEACH, Fla.– At the National Association of Chain Drug Stores (NACDS) Annual Meeting, the NACDS Foundation announced the addition of five first-time members to the NACDS Foundation board of directors. Each Director will serve a one-year term.
NACDS elects 2023-2024 officers, welcomes new members to board
PALM BEACH, Fla. – During the National Association of Chain Drug Stores (NACDS) Annual Meeting, NACDS elected new officers and one newly elected board of directors member for the coming year. Additionally, NACDS re-elected six board of directors members whose terms were set to expire.
Outcomes provides new answers to staff shortages
Two-thirds of pharmacy owners are struggling to fill open staffing positions, according to a January report from the National Community Pharmacists Association.
New CEO to build on strengths at L&R Distributors
Jim Athey has big plans for L&R Distributors. He’s just taken over as chief executive officer following the transition of Marc Bodner to the title of executive chair, and he’s ready to take the company to the next level. Athey spoke with Chain Drug Review about his blueprint for growth, the issues
With NACDS 2023, association helps define the future
In its 90th anniversary year, the National Association of Chain Drug Stores remains focused on leading the future of an industry dedicated to advancing health and wellness for all Americans. One of its major initiatives — NACDS 2023 — reflects this promise.
Big week ahead: Community pharmacy fly-In, house subcommittee hearing with PBM reform bill
ALEXANDRIA, Va. – The National Community Pharmacists Association and its members are gearing up for a significant week in Washington, D.C.
Bed Bath & Beyond files for bankruptcy protection
Bed Bath & Beyond Inc. said Sunday that it had filed for Chapter 11 bankruptcy protection and plans to “implement an orderly wind down of its businesses while conducting a limited marketing process to solicit interest in one or more sales of some or all of its assets.” To facilitate this process,
Annual Meeting marks NACDS’ 90th anniversary
PALM BEACH, Fla. – Leaders of the National Association of Chain Drug Stores (NACDS) on Sunday addressed a high-energy and robust audience of retailer and supplier members at the 2023 NACDS Annual Meeting, in the Association’s 90th Anniversary year.
Target joins Haleon for second ‘All for Wellness’ campaign
The shared values of Haleon and Target Corp. have led to the launch of their second annual All for Wellness campaign advancing equitable health care.
MinuteClinic mental health services launch in the Los Angeles metro area
MinuteClinic announced this week that it has launched mental health counseling and care services at six MinuteClinic locations in the Los Angeles metropolitan area. As recently as February 2023, more than 30% of adults in California reported symptoms of anxiety and/or depression.
Consumers shop drug stores for grocery and household items according to new study
JACKSONVILLE, Fla. – In advance of the 2023 National Association of Chain Drug Stores (NACDS) meeting later this month, a new proprietary Drug Store Channel Shopper Insights Study from Acosta Group highlights what consumers are shopping for in store and online.
Rite Aid narrows loss in fourth quarter
Rite Aid reported a net loss of $241.3 million, or $4.39 per share, for its fourth quarter, compared to a net loss of $389.1 million, or $7.18 per share in the year-ago period. The adjusted net loss of $68.2 million, or $1.24 per share, was wider than the 78 cents per share expected